Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Agenus Inc.
DescriptionAnti-cytotoxic T-lymphocyte associated protein 4 (CTLA4; CD152) mAb
Molecular Target Cytotoxic T-lymphocyte associated protein 4 (CTLA4) (CD152)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced or refractory solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today